Impact of Family Participation on Vaccination Decisions During the Outbreak: An Online Questionnaire Survey of Taiwanese People

Ching-Fang Wu¹, Shih-Chieh Fang^1, and Ching Ying Huang¹

¹Department of Business Administration, National Cheng Kung University, Tainan, Taiwan

Cite this paper:
Ching-Fang Wu, Shih-Chieh Fang and Ching Ying Huang. Impact of Family Participation on Vaccination Decisions During the Outbreak: An Online Questionnaire Survey of Taiwanese People. Journal of Business and Management Sciences. 2022; 10(1):39-45. doi: 10.12691/jbms-10-1-5

Abstract

COVID-19 is the most alarming public health crisis of the century. There have been many studies related to vaccine hesitancy to date. However, most of these studies discussed the influencing factors of vaccination decision-making from a micro level. Further, the influence of the relationship networks on personal decision-making was seldom addressed. This study mainly aimed to explore the acceptance level of the COVID-19 vaccine and its relationship with family participation among the Taiwanese population. An independently-developed questionnaire was used to conduct an online cross-sectional survey during Taiwan’s Level 3 alert period from June 30 to July 30, 2021. The study participants were people over 18 years of age and lived in Taiwan. A total of 1 108 participants were ultimately included in the analysis, and the logistic regression model was used for analysis. The study results showed that during Level 3 alert period, the vaccine acceptance level was high in Taiwan, with an overall 88.62% of the participants expressing their willingness to get vaccinated. The COVID-19 vaccination decision (willingness or undecided) was not associated with age, education level, or gender but with family members’ participation and participation level. The odds of “participants who would discuss with their families” was 0.596 times that of “participants who do not discuss with their families.” Therefore, for a unit increase in the family participation scale score, the odds of being willing to be vaccinated would decrease by 0.789. Specifically, the odds would be reduced by (0.454-1)*100% = 54.6%.

Keywords:
COVID-19 family participation vaccination decision-making logistic regression analysis

This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References:

[1]	Tsai, F. J., Hu, Y. J., Chen, C. Y., Tseng, C. C., Yeh, G. L., & Cheng, J. F. (2021). Using the health belief model to explore nursing students' relationships between COVID-19 knowledge, health beliefs, cues to action, self-efficacy, and behavioral intention: A cross-sectional survey study. Medicine (Baltimore), 100(11), e25210.
[2]	Wuhan pneumonia: First confirmed case in Seattle, United States. (2020). BBC NEWS. Retrieved from https://www.bbc.com/zhongwen/simp/world-51199732.
[3]	Samantha Beech, Jake Kwon, and Helen Regan (November 1, 2021) Global Covid-19 deaths surpass five million. CNN. Retrieved from https://edition.cnn.com/2021/11/01/world/covid-19-5-million-deaths-globally-intl-hnk/index.html.
[4]	Johns Hopkins University. Coronavirus Resource Center, https://coronavirus.jhu.edu.
[5]	Hsieh, C. C., Lin, C. H., Wang, W. Y. C., Pauleen, D. J., & Chen, J. V. (2020). The Outcome and Implications of Public Precautionary Measures in Taiwan-Declining Respiratory Disease Cases in the COVID-19 Pandemic. Int J Environ Res Public Health, 17(13).
[6]	Summers, J., Cheng, H. Y., Lin, H. H., Barnard, L. T., Kvalsvig, A., Wilson, N., & Baker, M. G. (2020). Potential lessons from the Taiwan and New Zealand health responses to the COVID-19 pandemic. Lancet Reg Health West Pac, 4, 100044.
[7]	Organization, W. H. (2020). Coronavirus disease (COVID-19) advice for the public: when and how to use masks. See https://ddl.ink/iZj1.
[8]	Randolph, H. E., & Barreiro, L. B. (2020). Herd Immunity: Understanding COVID-19. Immunity, 52(5), 737-741.
[9]	Kumar, D., Chandra, R., Mathur, M., Samdariya, S., & Kapoor, N. (2016). Vaccine hesitancy: understanding better to address better. Isr J Health Policy Res, 5, 2.
[10]	Benin, A. L., Wisler-Scher, D. J., Colson, E., Shapiro, E. D., & Holmboe, E. S. (2006). Qualitative Analysis of Mothers’ Decision-Making About Vaccines for Infants: The Importance of Trust. Pediatrics, 117(5), 1532-1541.
[11]	Opel, D. J., Mangione-Smith, R., Taylor, J. A., Korfiatis, C., Wiese, C., Catz, S., & Martin, D. P. (2011). Development of a survey to identify vaccine-hesitant parents. Human Vaccines, 7(4), 419-425.
[12]	Organization, W. H. (2015). Report of the SAGE working group on Vaccine Hesitancy. 2014. Paper presented at the Available on: https://ddl.ink/igko [Last accessed: 2017, Mar 21].
[13]	Salmon, D. A., Dudley, M. Z., Glanz, J. M., & Omer, S. B. (2015). Vaccine hesitancy: Causes, consequences, and a call to action. Vaccine, 33 Suppl 4, D66-71.
[14]	Paul, E., Steptoe, A., & Fancourt, D. (2021). Attitudes towards vaccines and intention to vaccinate against COVID-19: Implications for public health communications. Lancet Reg Health Eur, 1, 100012.
[15]	Lazarus, J. V., Ratzan, S. C., Palayew, A., Gostin, L. O., Larson, H. J., Rabin, K., . . . El-Mohandes, A. (2021). A global survey of potential acceptance of a COVID-19 vaccine. Nat Med, 27(2), 225-228.
[16]	Malik, A. A., McFadden, S. M., Elharake, J., & Omer, S. B. (2020). Determinants of COVID-19 vaccine acceptance in the US. EClinicalMedicine, 26, 100495.
[17]	Sherman, S. M., Smith, L. E., Sim, J., Amlôt, R., Cutts, M., Dasch, H., . . . Sevdalis, N. (2021). COVID-19 vaccination intention in the UK: results from the COVID-19 vaccination acceptability study (CoVAccS), a nationally representative cross-sectional survey. Hum Vaccin Immunother, 17(6), 1612-1621.
[18]	Wong, M. C. S., Wong, E. L. Y., Huang, J., Cheung, A. W. L., Law, K., Chong, M. K. C., . . . Chan, P. K. S. (2021). Acceptance of the COVID-19 vaccine based on the health belief model: A population-based survey in Hong Kong. Vaccine, 39(7), 1148-1156.
[19]	Tsai, F. J., Yang, H. W., Lin, C. P., & Liu, J. Z. (2021). Acceptability of COVID-19 Vaccines and Protective Behavior among Adults in Taiwan: Associations between Risk Perception and Willingness to Vaccinate against COVID-19. Int J Environ Res Public Health, 18(11).
[20]	Schwarzinger, M., Watson, V., Arwidson, P., Alla, F., & Luchini, S. (2021). COVID-19 vaccine hesitancy in a representative working-age population in France: a survey experiment based on vaccine characteristics. Lancet Public Health, 6(4), e210-e221.
[21]	Taiwan Centers for Disease Control. In response to the persistent severity of the local epidemic, the command center shall raise the national epidemic alert to the Level 3 from now until May 28. All localities shall simultaneously tighten and elevate epidemic prevention restrictions to protect the community defense lines. Press releaseRetrieved from http://at.cdc.tw/EM381M.
[22]	Larson, H. J., Clarke, R. M., Jarrett, C., Eckersberger, E., Levine, Z., Schulz, W. S., & Paterson, P. (2018). Measuring trust in vaccination: A systematic review. Human vaccines & immunotherapeutics, 14(7), 1599-1609.
[23]	Calina, D., Hartung, T., Docea, A. O., Spandidos, D. A., Egorov, A. M., Shtilman, M. I., . . . Tsatsakis, A. (2020). COVID-19 vaccines: ethical framework concerning human challenge studies. Daru, 28(2), 807-812.
[24]	Hodgson, S. H., Mansatta, K., Mallett, G., Harris, V., Emary, K. R. W., & Pollard, A. J. (2021). What defines an efficacious COVID-19 vaccine? A review of the challenges assessing the clinical efficacy of vaccines against SARS-CoV-2. Lancet Infect Dis, 21(2), e26-e35.
[25]	Thunström, L., Ashworth, M., Finnoff, D., & Newbold, S. C. (2021). Hesitancy Toward a COVID-19 Vaccine. Ecohealth, 18(1), 44-60.
[26]	Troiano, G., & Nardi, A. (2021). Vaccine hesitancy in the era of COVID-19. Public Health, 194, 245-251.
[27]	AlShurman, B. A., Khan, A. F., Mac, C., Majeed, M., & Butt, Z. A. (2021). What Demographic, Social, and Contextual Factors Influence the Intention to Use COVID-19 Vaccines: A Scoping Review. Int J Environ Res Public Health, 18(17).
[28]	Featherstone, J. D., Bell, R. A., & Ruiz, J. B. (2019). Relationship of people's sources of health information and political ideology with acceptance of conspiratorial beliefs about vaccines. Vaccine, 37(23), 2993-2997.
[29]	Ruiz, J. B., & Bell, R. A. (2021). Predictors of intention to vaccinate against COVID-19: Results of a nationwide survey. Vaccine, 39(7), 1080-1086.
[30]	Tsai, D. F.-C. (2010). Reflecting on the Nature of Confucian Ethics. The American Journal of Bioethics, 10(4), 84-86.
[31]	Cong, Y. (2004). Doctor-family-patient relationship: the Chinese paradigm of informed consent. J Med Philos, 29(2), 149-178.
[32]	Lin, M. L., Kan, W. M., & Chen, C. H. (2012). Patients’ perceptions and expectations of family participation in the informed consent process of elective surgery in Taiwan. Asian Nurs Res (Korean Soc Nurs Sci), 6(2), 55-59.
[33]	Lin, M. L., Pang, M. C., & Chen, C. H. (2013). Family as a whole: elective surgery patients’ perception of the meaning of family involvement in decision making. J Clin Nurs, 22(1-2), 271-278.
[34]	Tsai, D. F. (2005). The bioethical principles and Confucius’ moral philosophy. J Med Ethics, 31(3), 159-163.
[35]	Lamore, K., Montalescot, L., & Untas, A. (2017). Treatment decision-making in chronic diseases: What are the family members’ roles, needs, and attitudes? A systematic review. Patient Educ Couns, 100(12), 2172-2181.
[36]	Gray, T. F., Nolan, M. T., Clayman, M. L., & Wenzel, J. A. (2019). The decision partner in healthcare decision-making: A concept analysis. Int J Nurs Stud, 92, 79-89.
[37]	Survey Report on Digital Opportunities of Individual Households in 108 years. (2019). Survey report on digital opportunities (gap) over the years. Retrieved from https://www.ndc.gov.tw/cp.aspx?n=55c8164714dfd9e9.
[38]	DeVellis, R. F. (1991). Scale Development: Theory and Applications. Newbury Park: CA: Sage Publications.
[39]	Banerji, A., Wickner, P. G., Saff, R., Stone, C. A., Jr., Robinson, L. B., Long, A. A., . . . Blumenthal, K. G. (2021). mRNA Vaccines to Prevent COVID-19 Disease and Reported Allergic Reactions: Current Evidence and Suggested Approach. J Allergy Clin Immunol Pract, 9(4), 1423-1437.